Email
Print
Prostate Cancer Diagnostics Market - Forecast(2024 - 2030)
1. Prostate Cancer Diagnostics Market - Overview
1.1 Definitions and Scope
2. Prostate Cancer Diagnostics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Prostate Cancer Diagnostics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Prostate Cancer Diagnostics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Prostate Cancer Diagnostics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Prostate Cancer Diagnostics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Prostate Cancer Diagnostics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Prostate Cancer Diagnostics Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Prostate Cancer Diagnostics- By Geography (Market Size -$Million / $Billion)
11.1 Prostate Cancer Diagnostics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Prostate Cancer Diagnostics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Prostate Cancer Diagnostics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Prostate Cancer Diagnostics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Prostate Cancer Diagnostics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Prostate Cancer Diagnostics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Prostate Cancer Diagnostics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Prostate Cancer Diagnostics Market - Key Company List by Country Premium
15. Prostate Cancer Diagnostics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 3D Signature
15.3 Abbott
15.4 Beckman Coulter, Inc
15.5 Biomrieux Sa
15.6 Diasorin S P A
15.7 F Hoffman La Roche Ltd
15.8 Genomic Health
15.9 Mdxhealth
15.10 Myriad Genetic, Inc
15.11 Opko Health, Inc
15.12 Siemens Healthcare Gmbh
15.13 Company 12
15.14 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Prostate Cancer Diagnostics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Prostate Cancer Diagnostics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Prostate Cancer Diagnostics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Prostate Cancer Diagnostics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Prostate Cancer Diagnostics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Prostate Cancer Diagnostics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Prostate Cancer Diagnostics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Prostate Cancer Diagnostics Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Prostate Cancer Diagnostics Market - By Type(Market Size -$Million / $Billion)
9.1 Preliminary Test
9.2 Confirmatory Test
9.2.1 Confirmatory Test Market Estimate Segment Forecast
9.2.2 Pca3Test
9.2.3 Trans-Rectal Ultrasound
9.2.4 Biopsy
10. Prostate Cancer Diagnostics - By Application Type(Market Size -$Million / $Billion)10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Prostate Cancer Diagnostics- By Geography (Market Size -$Million / $Billion)
11.1 Prostate Cancer Diagnostics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Prostate Cancer Diagnostics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Prostate Cancer Diagnostics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Prostate Cancer Diagnostics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Prostate Cancer Diagnostics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Prostate Cancer Diagnostics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Prostate Cancer Diagnostics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Prostate Cancer Diagnostics Market - Key Company List by Country Premium
15. Prostate Cancer Diagnostics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 3D Signature
15.3 Abbott
15.4 Beckman Coulter, Inc
15.5 Biomrieux Sa
15.6 Diasorin S P A
15.7 F Hoffman La Roche Ltd
15.8 Genomic Health
15.9 Mdxhealth
15.10 Myriad Genetic, Inc
15.11 Opko Health, Inc
15.12 Siemens Healthcare Gmbh
15.13 Company 12
15.14 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Prostate Cancer Diagnostics Market - Appendix16.1 Abbreviations
16.2 Sources
17. Prostate Cancer Diagnostics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)1.1 Preliminary Test Market 2023-2030 ($M) - Global Industry Research
1.2 Confirmatory Test Market 2023-2030 ($M) - Global Industry Research
1.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
1.2.2 Pca3Test Market 2023-2030 ($M)
1.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
1.2.4 Biopsy Market 2023-2030 ($M)
2.Global Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 (Volume/Units)
2.1 Preliminary Test Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Confirmatory Test Market 2023-2030 (Volume/Units) - Global Industry Research
2.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 (Volume/Units)
2.2.2 Pca3Test Market 2023-2030 (Volume/Units)
2.2.3 Trans-Rectal Ultrasound Market 2023-2030 (Volume/Units)
2.2.4 Biopsy Market 2023-2030 (Volume/Units)
3.North America Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)
3.1 Preliminary Test Market 2023-2030 ($M) - Regional Industry Research
3.2 Confirmatory Test Market 2023-2030 ($M) - Regional Industry Research
3.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
3.2.2 Pca3Test Market 2023-2030 ($M)
3.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
3.2.4 Biopsy Market 2023-2030 ($M)
4.South America Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)
4.1 Preliminary Test Market 2023-2030 ($M) - Regional Industry Research
4.2 Confirmatory Test Market 2023-2030 ($M) - Regional Industry Research
4.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
4.2.2 Pca3Test Market 2023-2030 ($M)
4.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
4.2.4 Biopsy Market 2023-2030 ($M)
5.Europe Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)
5.1 Preliminary Test Market 2023-2030 ($M) - Regional Industry Research
5.2 Confirmatory Test Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
5.2.2 Pca3Test Market 2023-2030 ($M)
5.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
5.2.4 Biopsy Market 2023-2030 ($M)
6.APAC Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)
6.1 Preliminary Test Market 2023-2030 ($M) - Regional Industry Research
6.2 Confirmatory Test Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
6.2.2 Pca3Test Market 2023-2030 ($M)
6.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
6.2.4 Biopsy Market 2023-2030 ($M)
7.MENA Prostate Cancer Diagnostics Market:Type Estimate Trend Analysis Market 2023-2030 ($M)
7.1 Preliminary Test Market 2023-2030 ($M) - Regional Industry Research
7.2 Confirmatory Test Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Confirmatory Test Market Estimate Segment Forecast Market 2023-2030 ($M)
7.2.2 Pca3Test Market 2023-2030 ($M)
7.2.3 Trans-Rectal Ultrasound Market 2023-2030 ($M)
7.2.4 Biopsy Market 2023-2030 ($M)
LIST OF FIGURES
1.US Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)2.Canada Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
12.France Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
16.China Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
17.India Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Prostate Cancer Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Prostate Cancer Diagnostics By Application
22.South America Prostate Cancer Diagnostics By Application
23.Europe Prostate Cancer Diagnostics By Application
24.APAC Prostate Cancer Diagnostics By Application
25.MENA Prostate Cancer Diagnostics By Application
26.Mdxhealth, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.3D Signature, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Genomic Health, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Abbott, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Opko Health, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Siemens Healthcare Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Diasorin S P A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Biomrieux Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.F Hoffman La Roche Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Beckman Coulter, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Myriad Genetic, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)